Patents by Inventor Pamela Anne Hershberger

Pamela Anne Hershberger has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Estrogen antagonists as treatments for sclerosing disorders
    Patent number: 9655869
    Abstract: The present invention relates to methods and compositions for treating a subject suffering from a sclerosing disorder, comprising administering, to the subject, an effective amount of an estrogen receptor antagonist (“ERANT”), wherein said ERANT has essentially no estrogen receptor agonist activity under physiologic conditions.
    Type: Grant
    Filed: October 20, 2014
    Date of Patent: May 23, 2017
    Assignee: UNIVERSITY OF PITTSBURGH—OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION
    Inventors: Carol A. Feghali-Bostwick, Pamela Anne Hershberger
  • Estrogen antagonists as treatments for sclerosing disorders
    Patent number: 8969326
    Abstract: The present invention relates to methods and compositions for treating a subject suffering from a sclerosing disorder, comprising administering, to the subject, an effective amount of an estrogen receptor antagonist (“ERANT”), wherein said ERANT has essentially no estrogen receptor agonist activity under physiologic conditions.
    Type: Grant
    Filed: January 18, 2012
    Date of Patent: March 3, 2015
    Assignee: University of Pittsburgh—Of The Commonwealth System Of Higher Education
    Inventors: Carol A. Feghali-Bostwick, Pamela Anne Hershberger
  • ESTROGEN ANTAGONISTS AS TREATMENTS FOR SCLEROSING DISORDERS
    Publication number: 20150038468
    Abstract: The present invention relates to methods and compositions for treating a subject suffering from a sclerosing disorder, comprising administering, to the subject, an effective amount of an estrogen receptor antagonist (“ERANT”), wherein said ERANT has essentially no estrogen receptor agonist activity under physiologic conditions.
    Type: Application
    Filed: October 20, 2014
    Publication date: February 5, 2015
    Inventors: Carol A. Feghali-Bostwick, Pamela Anne Hershberger
  • ESTROGEN ANTAGONISTS AS TREATMENTS FOR SCLEROSING DISORDERS
    Publication number: 20120135971
    Abstract: The present invention relates to methods and compositions for treating a subject suffering from a sclerosing disorder, comprising administering, to the subject, an effective amount of an estrogen receptor antagonist (“ERANT”), wherein said ERANT has essentially no estrogen receptor agonist activity under physiologic conditions.
    Type: Application
    Filed: January 18, 2012
    Publication date: May 31, 2012
    Inventors: Carol A. Feghali-Bostwick, Pamela Anne Hershberger